Search research articles
Contact Us
Filters
Showing results (51-60 of 178) with videos related to
Page
of 18
Sort By:
Cancer Research Communications
|
August 9, 2023
Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model
Margot Passier, Maisa N G van Genderen, Anniek Zaalberg, et al.
FEBS Letters
|
June 2, 2024
Nuclear receptor Nur77 and Yin-Yang 1 synergistically increase mitochondrial abundance and activity in macrophages
Duco S Koenis, Inkie J A Evers-van Gogh, Pieter B van Loenen, et al.
Genome Research
|
June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts
Yanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
The Journal of Pathology
|
June 8, 2018
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling
Marieke van de Ven, Xiaoling Liu, Eline van der Burg, et al.
Communications Biology
|
July 11, 2025
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination
Nils Eickhoff, Janina Janetzko, Nuno Padrão, et al.
Breast Cancer Research and Treatment
|
August 5, 2011
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
Oscar Krijgsman, Paul Roepman, Wilbert Zwart, et al.
BMC Cancer
|
August 15, 2015
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13
Cristiane Bentin Toaldo, Xanthippi Alexi, Karin Beelen, et al.
Molecular Cancer Research : MCR
|
January 21, 2016
Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
Guus J J E Heynen, Ekaterina Nevedomskaya, Sander Palit, et al.
International Journal of Cancer
|
September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer
Dinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Clinical Epigenetics
|
May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 178) with videos related to
Sort By:
Page
of 18
Cancer Research Communications
|
August 9, 2023
Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model
Margot Passier, Maisa N G van Genderen, Anniek Zaalberg, et al.
FEBS Letters
|
June 2, 2024
Nuclear receptor Nur77 and Yin-Yang 1 synergistically increase mitochondrial abundance and activity in macrophages
Duco S Koenis, Inkie J A Evers-van Gogh, Pieter B van Loenen, et al.
Genome Research
|
June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts
Yanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
The Journal of Pathology
|
June 8, 2018
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling
Marieke van de Ven, Xiaoling Liu, Eline van der Burg, et al.
Communications Biology
|
July 11, 2025
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination
Nils Eickhoff, Janina Janetzko, Nuno Padrão, et al.
Breast Cancer Research and Treatment
|
August 5, 2011
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
Oscar Krijgsman, Paul Roepman, Wilbert Zwart, et al.
BMC Cancer
|
August 15, 2015
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13
Cristiane Bentin Toaldo, Xanthippi Alexi, Karin Beelen, et al.
Molecular Cancer Research : MCR
|
January 21, 2016
Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
Guus J J E Heynen, Ekaterina Nevedomskaya, Sander Palit, et al.
International Journal of Cancer
|
September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer
Dinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Clinical Epigenetics
|
May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
Page
of 18